2025 International Congress

October 5-9, 2025. Honolulu, Hawaii.

View by Title View Categories

Jump to: View All • a b c d e f g h i j k l [m] n o p q r s t u v w x y z

Machine Learning Analysis of DTI-Derived Free Water Reveals Distinct Parkinson’s Disease Subtypes: A Two-Year Longitudinal Study

A. Vijayakumari, H. Fernandez, B. Walter (Cleveland, USA)
Machine Learning Model using Eye Movements for the Differential Diagnosis of iPD and Atypical Parkinsonian Syndromes

A. Sekar, D. Kaski (London, United Kingdom)
Machine-learning Prediction of Cognition in Parkinson’s disease: Benchmarking EEG Source Functional Connectivity and Structural MRI

A. Tetereva, G. Hall-Mcmaster, N. Slater, A. Harris, R. Shoorangiz, C. Le Heron, R. Keenan, I. Kirk, W. Meissner, T. Anderson, T. Melzer, J. Dalrymple-Alford, N. Pat (Christchurch, New Zealand)
Magnetic Resonance Guided Focused Ultrasound for Essential Tremor and Tremor dominant Parkinson’s Disease Case Series

M. Jayasree, M. Panigrahi, G. Gorrepati (Hyderabad, India)
Malnutrition Risk in Huntington’s Disease: A Cohort Study on Prevalence and Prognosis with Mendelian Randomization Validation

YF. Cheng, HF. Shang (Chengdu, Sichuan, China)
Management of Grisel’s Syndrome with Botulinum Toxin: A Case Report

L. Kenjaeva, A. Azimov, G. Kendjaeva (Tashkent, Uzbekistan)
Management of peri-lead cyst after Deep Brain Stimulation surgery: Review of literature and an illustrative case report

V. Srinivasa Rangan, . (Hyderabad, India)
Mapping aggregate monopolar sensing data of beta power local field potentials onto a common subthalamic nucleus in Parkinson’s disease patients

M. Case, C. Zarns, A. Holt-Becker, R. Raike, E. Radcliffe, A. Baumgartner, J. Thompson, D. Kern (Minneapolis, USA)
Mass spectrometry-based screening for α-synuclein bioactive marine natural products

F. Ferretti, M. Xu, D. Prebble, G. Mellick, A. Carroll (Gold Coast, Australia)
Mathematical and Computational Modeling Prototype to Understand the Evolution of Parkinson’s disease using Four Differential Equations

G. Sa, A. Rodrigues Tavares, M. Silva Bissaco (Mogi das Cruzes, Brazil)
MDS Task Force on Tic Disorders: Development of a New Classification Scheme for Tic Disorders

I. Malaty, K. Bhatia, K. Black, F. Cardoso, D. Gilbert, M. Hallett, J. Jimenez-Shahed, D. Martino, A. Munchau, M. Okun, P. Pal, J. Piacentini, T. Pringsheim, Y. Worbe, C. Ganos (London, United Kingdom)
Mechanical Peripheral Stimulation for the Treatment of Gait Disorders in Patients with Parkinson’s Disease (GONDOPARK): A Multi-centre, Double-blind, Crossover Randomized Controlled Trial

MD. de Pandis, TC. Carlo, SP. Proietti, LL. Leonardi, MG. Gaglione, MC. Casali, LD. Di Biase, MG. Galli, MG. Goffredo, FS. Stocchi (Roma, Italy)
Mechanistic Insights of Tamarindus indica in Acrylonitrile-Induced Neurodegeneration

L. Usman, E. Ajani, A. Akinmoladun, R. Ibrahim, R. Aladodo (Ilorin, Nigeria)
Medication Administration Burden in Lewy Body Dementia Caregivers

W. Ayele, J. Hemm, S. Mitchell Chen, E. Stevens, A. Taylor, K. Fargo, D. Mariani, S. Seshadri, C. Bentley, T. Manak, A. Miller, C. Pensyl, C. Pierce, M. Voss, B. Ouyang, J. Chodosh, J. Fleisher (Chicago, USA)
Medication Error Reduction Strategies in an In-patient Multimodal Intensive Neurorehabilitation and Care (i-MINC) Program

N. Yousefzadeh, L. Hom, A. Defrank, M. Mccrossin, L. Rubin (Glen Cove, USA)
Medication therapy in Parkinson’s disease patients: a cross-sectional study at the University Medical Center at Ho Chi Minh City, Vietnam

T. Dang, T. Tran (HO CHI MINH, Viet Nam)
Metabolic dysfunction-associated steatotic liver disease, body mass index, and risk of Parkinson’s disease

SJ. Chung, TS. Lim, J. Jeon, JK. Kim, J. Kim, PH. Lee (Seoul, Republic of Korea)
Metabolic Imaging Correlates of Apathy in Parkinson’s Disease.

J. Arena, M. Ponce-de-Leon, L. Fiorentini, C. Obarrio, S. Vazquez, Y. Bergamo, M. Merello (Buenos Aires, Argentina)
Metabolic network signature of quantitative motor effects following deep brain stimulation in Parkinson’s disease

A. Calvano, A. Turan, U. Kleinholdermann, V. Heinecke, K. Steidel, L. Ruesing, F. Thiemig, D. Librizzi, T. Schurrat, M. Beckersjuergen, M. Luster, L. Timmermann, C. Eggers, M. Ruppert-Junck, D. Pedrosa (Marburg, Germany)
Metabolic Patterns in Multiple System Atrophy: Brain Network Insights from Spatial ICA of FDG-PET

J. Li, H. Wang, B. Wang, Z. Cen, W. Luo (Hangzhou, China)
Metabolomic breath landscape analysis unravels lipid biomarker candidates in patients with monogenic and idiopathic Parkinson’s disease

M. Malik, N. Brüggemann, T. Usnich, M. Borsche, T. Demetrowitsch, K. Schwarz, P. Bauer, K. Lohmann, C. Klein, T. Kunze (Luebeck, Germany)
Metabolomic Profiling in an Egyptian Cohort Reveals Altered Phenylalanine Metabolism and Suggests a Role for Trans-Cinnamate in Parkinson Disease

N. Shebl, S. El-Jafaary, A. Saeed, P. Elkafrawy, A. El-Sayed, S. Shamma, R. Elmer, J. Mekky, L. Mohamed, O. Kittaneh, H. El-Fawal, M. Rizig, M. Salama (Cairo, Egypt)
Metabolomics Profiling in Egyptian Patients with Alzheimer’s and Parkinson’s Diseases

S. Abdelaziz, A. Helmy, E. Hamid, M. Salama, A. Shalash (Cairo, Egypt)
Methodological considerations supporting a time-to-event primary endpoint in the PADOVA study in early-stage Parkinson’s disease participants on stable symptomatic treatment

N. Pross, G. Pagano, D. Trundell, J. Anzures-Cabrera, T. Simuni, K. Marek, N. Pavese, K. Seppi, F. Stocchi, R. Postuma, A. Monnet, L. Rutten-Jacobs, G. Respondek, L. Boak, G. Kerchner, P. Brundin, H. Svoboda, T. Nikolcheva, A. Bonni (Basel, Switzerland)
Microglial Activation and Phenotype in Air Pollution Neurotoxicity: Implications for Parkinson’s Disease

A. Tang-Tan, K. Shkirkova, A. Demetriou, S. Chen, C. Bent, L. Zhao, M. Thorwald, J. Godoy-Lugo, C. Sioutas, C. Pike, C. Finch, W. Mack (Los Angeles, USA)
MicroRNA Landscape of Multiple System Atrophy: Insights from Plasma and Patient-Derived Induced Pluripotent Stem Cell Models

K. Kuo, C. Chen, L. Lin, W. Wu (Taipei, Taiwan)
Microstructural Changes in the Striatum Correlate With Clinical Symptoms in Wilson Disease

A. Hausmann, S. Querbach, C. Rubbert, A. Schnitzler, J. Caspers, C. Hartmann (Düsseldorf, Germany)
Mind-Body Treatment For Managing Functional Weakness: A Pilot Study

L. Tesolin, S. Calizaya, M. Lobos, M. Villar (Bolzano, Italy)
Minimally Invasive Magnetic Resonance Imaging guided Deep Brain Stimulation for Movement Disorders – A Novel technique, Accuracy and Clinical Outcome.

J. Shah, F. Panov (NEW YORK, USA)
Mining Metabolomics GWAS for Key Parkinson’s Disease Variants: A Bioinformatics Approach to Genetic-Metabolic Associations

S. Rodríguez-Quiroga, T. Ascencio, J. Largo Gonzalez, S. Peña Martinez, L. Hernandez Delgado, A. Noyce, M. Tan (Buenos Aires, Argentina)
Mitigating Risk and Expanding Movement Disorder Specialist Capacity: Advancing Parkinson’s Disease Management with Integrated Monitoring, Targeted Triage and Improved Patient-Clinician Communication in Parkinson’s Disease.

A. Arnold, T. Jansen, A. Hare, S. Shaffer, S. Khandhar, R. Gilron (San Francsico, USA)
Modeling Dementia in Patients with Parkinson’s Disease Years After DBS

S. Gunawardena, E. Assaedi, T. George, C. Sonneborn, D. Floden (Cleveland, USA)
Modeling Inflammation in GBA-Associated Parkinson’s Disease: Insights into Disease Mechanisms

V. Lentini, G. Uras, S. Lucas, D. Moreno-Martinez, A. Manca, F. Fierli, S. Koletsi, A. Pantaleo, D. Hughes (Sassari, Italy)
Modeling Levodopa Resistance in Parkinson’s Disease: A Novel Approach Targeting Locus Coeruleus Degeneration

A. Goel, R. Goel (Bathinda, India)
Modification of Parkinson’s Disease Сourse Using Cell Technologies

V. Chyzhyk, V. Ponomarev, A. Boika (Minsk, Belarus)
Modified Delphi consensus approach to develop recommendations for diagnosis, evaluation and management of cognitive disorders in Parkinson’s disease

D. Pourzinal, D. Brooks, D. Sriram, L. Mitchell, N. Pachana, K. Shrubsole, B. Wood, J. O'Sullivan, R. Marsh, A. Lehn, J. Liddle, E. Tan, WK. Halford, N. Page, N. Dissanayaka (HERSTON, Australia)
Modified Timed Up and Go test as a marker for motor improvement in advanced Parkinson’s disease after in-patient multimodal intensive neurorehabilitation and care

M. Mccrossin, F. Avantaggiato, E. Cipparonne, L. Rubin, A. Di Rocco (Glen Cove, USA)
Modifiers of Parkinson’s disease associated with mutations in the GBA1 gene based on transcriptome data validation

A. Bezrukova, K. Basharova, I. Miliukhina, S. Pchelina, T. Usenko (Gatchina, Russian Federation)
Modifying Effect of a Long-term Repeated Therapy of repetitive Transcranial Magnetic Stimulation combined with Lidocaine Injection (rTMS-LI) on Dystonia

N. Murase, R. Urushihara, S. Matsumoto, K. Sato, K. Asanuma, H. Shimazu, R. Kaji (Nara city, Japan)
Modulation of working memory in prodromal DLB by non-invasive brain stimulation of the striatum and cerebellum

I. Rektorová, M. Pupikova, . Gajdoš (Brno, Czech Republic)
Molecular Studies Reveal Overactive Interferon (IFN) Pathway in Two Monogenic Inherited Dystonia Types.

S. Avula, E. Swager, R. Patel (Columbia, USA)
Monitoring Parkinson’s Disease in the Dental Chair

J. Schwartz, L. Dibenedetto, P. Engen, V. Ha, B. Killinger, C. Soto, S. Green, A. Naqvi, S. Tomar, M. Shaikh, M. Villanueva, D. Sanchez-Bass, C. Noh, R. Voigt, C. Goetz, A. Keshavarzian (Chicago, USA)
Monogenic Parkinson’s Disease patients in Central Europe within the CEGEMOD consortium

M. Ostrozovicova, G. Tamas, P. Dusek, M. Grofik, V. Han, P. Holly, R. Jech, P. Klivenyi, N. Kovacs, E. Kurca, A. Lackova, J. Necpal, D. Pinter, E. Ruzicka, T. Serranova, K. Smilowska, I. Straka, T. Svorenova, P. Valkovic, K. Zarubova, H. Houlden, M. Rizig, M. Skorvanek (Kosice, Slovakia)
Morbidity and Mortality Associated with Aspiration Pneumonia: Nationwide Trends in Inpatient Therapy Utilization in Parkinson’s Disease Hospitalization

T. Mehta, H. Kamo, R. Burke, M. Rem, M. Okun, C. Hess (Gainesville, USA)
Mortality and Institutionalisation Following de Novo Use of Rotigotine Patches in Hospitalised Patients with Parkinson’s Disease

E. Kaye, K. Millington, R. Skelly (Nottingham, United Kingdom)
Mortality Trends Associated with Parkinson’s Disease with Diabetes Mellitus in the United States (1999-2020)

T. Patel, R. Khan, M. Athar, S. Aleem, A. Khan, M. Altaf, A. Khan, M. Shahabi, B. Aslam, E. Zulfiqar, R. Millis, A. Awosika (Kingstown, Saint Vincent and the Grenadines)
Motor & Non-Motor Symptoms in nOH & RBD

M. Meyers, G. Smith, K. Bigos, J. Leoutsakos (Baltimore, USA)
Motor Fluctuations in Parkinsons Disease and their Correction

M. Ganieva (Dushanbe, Tajikistan)
Motor Outcomes Following Subthalamic Nucleus or Globus Pallidus Interna Deep Brain Stimulation in Early-Onset Parkinson’s Disease

G. Hey, H. Kamo, G. Rodriguez Garcia, T. Mehta, J. Hilliard, R. Eisinger, A. Ramirez-Zamora (Gainesville, USA)
Movement disorders as a manifestation of aceruloplasminemia a case report

A. Camargo (Bogota, Colombia)
Movement Disorders in Autoimmune Encephalitis a Cohort

A. Catunda, AS. Lima Verde, F. Rolim, G. Martins, PC. Matos, F. Carvalho, M. Pitombeira (Fortaleza, Brazil)
Movement-Disorders Focused Clinical Neuroscience Training for Psychiatry Residents: A Competency-Based Medical Education Model

A. Seritan (San Francisco, USA)
Moyamoya Disease and the Risk of Parkinson’s Disease

D. Yoo, J. Shin, R. Lee, J. Cheon, J. Kim, J. Won, I. Oh, Y. Lee, T. Ahn (Suwon, Republic of Korea)
MS-Related Tremor in a Patient with Multiple Sclerosis Treated with Thermal Ablation of the Left Ventral Intermediate (VIM) Thalamic Nucleus: The Role of Tractography-Guided Targeting

F. Fenner, E. da Silva, W. Morikawa, E. Gisoldi, A. Venturi, G. Chung (Sao Paulo, Brazil)
Mucuna pruriens for FOG in Parkinson’s disease, Do we have a solution for this trivial problem?

M. Matta, N. Sawal, S. Singh, K. Verma, S. Sharma (Chandigarh, India)
Multidimensional Assessment of Levodopa/Carbidopa/Entacapone Gel (LECIG) Therapy in Parkinson’s Disease: Perspectives of Patients, Clinicians, and Caregivers

M. Minar, I. Straka, Z. Andre, M. Grofik, J. Necpal, M. Rusinkova, V. Han, Z. Kosutzka (Bratislava, Slovakia)
Multidisciplinary Approach to Patients with Movement Disorders in Uzbekistan: A 2024 Review.

B. Mukhammedaminov, L. Kenjaeva, N. Aripova, Y. Nishonova (Tashkent, Uzbekistan)
Multidisciplinary Approaches to Palliative Care in Late-Stage Parkinson’s Disease: A Review of Educational Tools and Frameworks

M. Farghaly, H. Khabiry, O. Sabry, A. Nagah, O. Awadalla, M. Elsayed (Giza, Egypt)
Multimodal and Agentic Simulated AI Patients for Bridging the gap in Parkinson Disease Education

L. Okar, M. Fani (St. Louis, USA)
Multimodal Dissection of GALC Variants Linking Olfactory Deficits to Cognitive Decline in Parkinson’s Disease

Y. Li, M. Zhong, J. Liu (shanghai, China)
Multimodal imaging Integrating 18F-APN-1607 and 18F-FP-DTBZ PET in Progressive Supranuclear Palsy

C. Dong, J. Ma, S. Liu (Beijing, China)
Multimodal Neurophysiological Evaluation in Patients with Different Dystonia Subtypes

T. Grippe, N. Sheth, A. Bhattacharya, JC. Chen, N. Raies, H. Taskin, N. Naeini, R. Annirood, JF. Nankoo, J. Baarbe, R. Chen (Toronto, Canada)
Multimodal Sensing-Enabled Diagnosis and Assessment of Parkinson’s Disease via Biomolecule and Biomechanics Signals

M. Zhang, D. Chen, H. Cao (Xi'an, China)
MultiModal Transformer-Based Detection of Parkinson’s Disease in fMRI Extracted Time Series

S. Patel, C. Antoniades, J. Fitzgerald, O. Bredemeyer (Oxford, United Kingdom)
Multiparametric Prediction of Mild Cognitive Impairment in Parkinson’s Disease Using a Combination of Structural and Functional MRI Measures

G. Rathi, T. Davis, J. Caldwell, Z. Mari, V. Mishra (Birmingham, USA)
Multiple Independent Current Control for Gait Disorders in Early Programming of Parkinson’s Disease

N. Helvacı Yılmaz, B. Bolluk Kılıç, G. İbrahimova, ö. Köksal, S. Bostan, B. Arı, T. Zırh, G. Kenangil (Istanbul, Turkey)
Multiple System Atrophy found during Evaluation of Palatal Myoclonus

H. Kelly, T. Gregory, J. Fang (Nashville, USA)
Multiplex Proteomic Analysis of Lewy Body Dementia Reveals Cerebrospinal Fluid Biomarkers of Disease Pathophysiology and Progression

L. Higginbotham, A. Shantaraman, Q. Guo, E. Fox, P. Bagchi, F. Wu, J. Lah, A. Levey, N. Seyfried (Altanta, USA)
Multipronged, Community-Engaged Approach to Recruiting Lewy Body Dementia Family Caregivers for a National Trial

J. Hemm, W. Ayele, S. Mitchell Chen, E. Stevens, A. Taylor, K. Fargo, D. Mariani, S. Seshadri, C. Bentley, T. Manak, A. Miller, C. Pensyl, C. Pierce, M. Voss, B. Ouyang, J. Chodosh, J. Fleisher (Chicago, USA)
Multiscale entropy: a New Oculomotor Measure of PSP.

C. O'Keeffe, A. Gallagher, J. Inocentes, B. Coe, B. White, D. Brien, D. Munoz, R. Walsh, T. Lynch, C. Fearon (Dublin, Ireland)
Muscle Coactivation in subjects with Parkinson’s Disease: a Healthy-matched analysis of the Sub-Phases of Gait Cycle

D. Bonacina, D. Tosatto, M. Leonardi, C. Perin, C. Alessandro, D. Piscitelli (Milano, Italy)
Muscle Interactions during Gait in People with Parkinson’s Disease

D. Tosatto, D. Bonacina, F. Fumagalli, A. Alessandro, C. Perin, D. Piscitelli (Milano, Italy)
Mutations of the VPS13A gene in a patient with Early-Onset Parkinson’s Disease: A case report.

H. Pacheco, V. Gómez, C. Sánchez, L. Núñez (Mexico, Mexico)
Myofascial pain syndromes in parkinsonism

R. Matmurodov, E. Abduqodirov, A. Kalanov, F. Babayeva, S. Jamalova (Tashkent, Uzbekistan)
Myorhythmia: A Quantitative Study of Synchrony and Rhythmicity Between The Head and Upper Limbs

M. Elkhooly, A. El Kouzi, R. Elble (Springfield, USA)

Jump to: View All • a b c d e f g h i j k l [m] n o p q r s t u v w x y z